Chemotherapy is a type of systemic anti-cancer therapy (SACT). Chemotherapy information sheets provide details about individual chemotherapy treatments.
We also have a number of immunotherapy information sheets. Immunotherapy is a treatment which uses your immune system to fight cancer. It works by helping the immune system recognise and attack cancer cells. Some types of immunotherapy are also called targeted treatments or biological therapies.
Your doctor will discuss your treatment with you when you come to The Christie.
Each information sheet includes:
- name of drugs
- the way the drugs are given, for example, injection or via a drip
- treatment cycle (which days or weeks you have treatment and how long treatment lasts)
- side effects and how to cope
- contact numbers
Click on the name of the treatment you wish to view.
A
Anastrozole [PDF, 164 KB]
You can also read this information in an accessible format on our Anastrozole page.
B
C
D
Docetaxel, carboplatin, pertuzumab and trastuzumab (TCarboPH) [PDF, 104 KB]
You can also read this information in an accessible format on our Docetaxel, carboplatin, pertuzumab and trastuzumab (TCarboPH) page.
E
Epirubicin, cyclophosphamide then docetaxel, trastuzumab (EC-TH) [PDF, 104 KB]
You can also read this information in an accessible format on our Epirubicin, cyclophosphamide then docetaxel, trastuzumab (EC-TH) page.
Epirubicin, cyclophosphamide then paclitaxel and trastuzumab (EC-PH) [PDF, 104 KB]
You can also read this information in an accessible format on our Epirubicin, cyclophosphamide then paclitaxel and trastuzumab (EC-PH) page.
Exemestane [PDF, 167 KB]
You can also read this information in an accessible format on our Exemestane page.
F
G
Glofitamab, gemcitabine and oxaliplatin [PDF, 98 KB]
You can also read this information in an accessible format on our Glofitamab, gemcitabine and oxaliplatin page.
H
High dose melphalan conditioning for autologous transplant (inpatient) [PDF, 170 KB]
Before you can receive your transplant, your bone marrow and immune system need to be prepared to make way for the new cells. This is called conditioning. Your new cells will be scheduled for reinfusion into you the day after the conditioning therapy has finished.
I
Ibandronic acid for metastatic breast cancer [PDF, 167 KB]
You can also read this information in an accessible format on our Ibandronic acid for breast cancer page.
L
Letrozole [PDF, 170 KB]
You can also read this information in an accessible format on our Letrozole page.
M
N
Niraparib (Zejula®) [PDF, 101 KB]
Niraparib (Zejula®) is a systemic anti-cancer therapy. This group of drugs targets and interferes with the processes in the cells that cause cancer to grow.
O
Obinutuzumab (lymphoma) [PDF, 86KB]
You can also read this information in an accessible format on our Obinutuzumab (lymphoma) page.
P
Pembrolizumab and lenvatinib (Lenvima®) [PDF, 172 KB]
Pembrolizumab is a type of anti-cancer treatment called immunotherapy. Lenvatinib (Lenvima®) is a systemic anticancer therapy. This group of drugs stops cancer cells from growing.
R
Ribociclib [PDF, 103 KB]
You can also read this information in an accessible format on our Ribociclib page.
S
Systemic anti-cancer treatment (SACT): A guide for patients and their carers (previously called chemotherapy) [PDF, 1,017 KB]
Previously the 'Chemotherapy: A guide for patients and their carers' booklet. You can also read this information in an accessible format on our Systemic anti-cancer therapy (SACT) website section.